MoneyWorks4Me

The September 2024 quarter revenue stood at Rs. 26360.99 millions, up 18.03% as compared to Rs. 22334.16 millions during the corresponding quarter last year.Net profit surges 96.81% to Rs. 5950.56  millions  from Rs. 3023.54 millions in the quarter ended September 2024.Operating profit for the quarter ended September 2024 rose to 8617.03 millions as compared to 5170.68 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 26360.99 22334.16 18.03 49656.36 43778.00 13.43 78911.19 82206.62 -4.01
Other Income 830.77 735.78 12.91 1387.25 1229.39 12.84 11680.24 9859.39 18.47
PBIDT 8617.03 5170.68 66.65 15484.53 10514.25 47.27 24096.87 24587.06 -1.99
Interest 117.95 581.87 -79.73 271.44 1201.21 -77.40 2771.10 2068.16 33.99
PBDT 8499.08 4392.12 93.51 15213.09 8800.06 72.87 72029.08 17560.22 310.18
Depreciation 548.49 498.46 10.04 1079.36 985.98 9.47 2021.62 1841.48 9.78
PBT 7950.59 3893.66 104.19 14133.73 7814.08 80.88 70007.46 15718.74 345.38
TAX 2000.03 870.12 129.86 3645.86 2073.98 75.79 18334.55 3631.05 404.94
Deferred Tax 615.40 777.97 -20.90 1181.39 1596.18 -25.99 7834.63 -238.26 -3388.27
PAT 5950.56 3023.54 96.81 10487.87 5740.10 82.71 51672.91 12087.69 327.48
Equity 282.19 282.17 0.01 282.19 282.17 0.01 282.19 282.17 0.01
PBIDTM(%) 32.69 23.15 41.19 31.18 24.02 29.84 30.54 29.91 2.10
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..